To further assess the metabolic response to EVAML, we performed Seahorse analysis on both cell lines, i.e., KG-1 and MOLM-13, which were shown to be more responsive to EVAML, and on primary CD34+ AML cells. Here, CD34 is linked to acute myeloid leukemia.